--2025/Q1-- / 52.992M--
--2024/Q4-- / 45.954M--
Nov 7, 20242024/Q341.673M / 36.592M--
Aug 5, 20242024/Q249.859M / 22.234M--
May 8, 20242024/Q138.012M / 17.672M--
US Stock MarketDetailed Quotes
ARCT Arcturus Therapeutics
- 17.130
- +0.960+5.94%
Trading Nov 21 15:40 ET
464.01MMarket Cap-7351P/E (TTM)
17.300High15.505Low297.58KVolume16.220Open16.170Pre Close4.90MTurnover1.20%Turnover RatioLossP/E (Static)27.09MShares45.00052wk High1.77P/B424.84MFloat Cap14.93052wk Low--Dividend TTM24.80MShs Float129.710Historical High--Div YieldTTM11.10%Amplitude4.110Historical Low16.466Avg Price1Lot Size
Arcturus Therapeutics Key Stats
Arcturus Therapeutics Q3 2024 Earnings Date
Currency：USDNov 7, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 36.59M | 41.67M | +5.08M |
| Beat Est. | -18.94% | -7.68% | +13.89% |
| EPS | -1.14 | -0.26 | +0.88 |
| Beat Est. | -86.36% | +57.38% | +77.12% |
Analyst Rating
Nov 21, 2024
Arcturus Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Arcturus Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data